Group 1 - The Hong Kong Innovative Drug ETF managed by Penghua (159286) experienced a decline of 0.56% on January 12, with a trading volume of 73.0144 million yuan [1] - The fund's shares decreased by 5 million, bringing the total shares to 671 million, with a reduction of 10 million shares over the last 20 trading days [1] - The latest net asset value of the fund is calculated to be 602 million yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the National Index of Hong Kong Innovative Drugs, adjusted for exchange rates [1] - The fund has been managed by Penghua Fund Management Co., with fund managers Lin Song and Zhang Yuxiang [1] - Since its establishment on August 20, 2025, the fund has reported a return of -10.29%, while the return over the past month is 2.28% [1]
1月12日港股创新药ETF鹏华（159286）份额减少500.00万份
Xin Lang Cai Jing·2026-01-13 01:09